Dr Tuddenham wrote to John Canavan to support the move to evaluate the test based on detection of antibody to polypeptide synthesised by recombinant yeast clones of the HCV virus. This is because screening donor blood by such an assay could reduce the transmission rate of non-A non-B Hepatitis in single donor products and in some pooled plasma derivatives.